1391740-89-8

Basic information

• Product Name: ethyl 4-(4-methoxybenzylamino)-6-chloropyridine-3-carboxylate
• Synonyms: ethyl 4-(4-methoxybenzylamino)-6-chloropyridine-3-carboxylate
• CAS NO: 1391740-89-8
• Molecular Weight: 320.776
• Mol File: 1391740-89-8.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: ethyl 4-(4-methoxybenzylamino)-6-chloropyridine-3-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 4-(4-methoxybenzylamino)-6-chloropyridine-3-carboxylate(1391740-89-8)
• EPA Substance Registry System: ethyl 4-(4-methoxybenzylamino)-6-chloropyridine-3-carboxylate(1391740-89-8)

Safety Data

• Hazardous Substances Data: 1391740-89-8(Hazardous Substances Data)

Upstream product

• 40296-46-6 ethyl 4,6-dichloronicotinate 
• 2393-23-9 4-methoxy-benzylamine 

Downstream Products

• 1455036-34-6 N-(3-(3-amino-4-fluorophenyl)-2-methyl[1,6]naphthyridin-7-yl)cyclopropanecarboxamide 
• 1455036-62-0 prop-1-en-2-yl (2-fluoro-5-(7-((4-methoxybenzyl)(methyl)amino)-2-methyl[1,6]naphthyridin-3-yl)phenyl)carbamate 
• 1455037-46-3 1-(3,3-dimethylbutyl)-3-(2-fluoro-5-(7-((4-methoxybenzyl)(methyl)amino)-2-methyl-1,6-naphthyridin-3-yl)phenyl)urea 
• 1455033-39-2 1-(3,3-dimethylbutyl)-3-(2-fluoro-5-(2-methyl-7-(methylamino)-1,6-naphthyridin-3-yl)phenyl)urea 
• 1455030-47-3 1-(3,3-dimethylbutyl)-3-(2-fluoro-5-(2-methyl-7-(methylamino)-1,6-naphthyridin-3-yl)phenyl)urea hydrochloride 
• 1455037-95-2 1-(5-(7-chloro-2-methyl-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-cycloheptylurea 
• 1455038-10-4 prop-1-en-2-yl (5-(7-chloro-2-methyl-1,6-naphthyridin-3-yl)-2-fluoro-4-methylphenyl)carbamate 
• 1455038-18-2 1-(5-(7-chloro-2-methyl-1,6-naphthyridin-3-yl)-2-fluoro-4-methylphenyl)-3-(3,3,3-trifluoropropyl)urea 
• 380626-81-3 ethyl 4-amino-6-chloropyridine-3-carboxylate 
• 1455038-64-8 1-(5-(7-chloro-2-methyl-1,6-naphthyridin-3-yl)-2-fluoro-4-methylphenyl)-3-(2-cyclobutylethyl)urea 
• 846036-96-2 (4-amino-6-chloropyridin-3-yl)methanol 
• 1001756-21-3 4-amino-6-chloropyridine-3-carboxaldehyde 
• 1455035-79-6 5-(7-chloro-2-methyl-1,6-naphthyridin-3-yl)-2-fluoroaniline 
• 1455035-98-9 5-(7-chloro-2-methyl[1,6]naphthyridin-3-yl)-2-fluoro-4-methylaniline 

Relevant articles and documents

NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS

The present invention discloses compounds according to Formula (I): (I). Wherein R1, R2, R5 and Cy are as defined herein. The present invention relates to compounds, methods for the production of said compounds, pharmaceutical compositions comprising said compounds and methods for the prophylaxis and/or treatment of inflammatory diseases, autoimmune diseases, pain, fibrosis and/or proliferative diseases by administering said compounds.

CHEMICAL COMPOUNDS AS H-PGDS INHIBITORS

A compound of formula (I) wherein R1, R2, R3, R4, X, Y, and A are as defined herein. The compounds of the present invention are inhibitors of hematopoietic prostaglandin D synthase (H-PGDS) and can be useful in the treatment of Duchenne muscular dystrophy. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting H-PGDS activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

QUINAZOLINONE DERIVATIVE

PROBLEM TO BE SOLVED: To provide a novel compound having effects on 5-HT5A receptor and useful as a therapeutic agent and/or a preventive agent of psychiatric disorders and neurodegenerative diseases to which 5-HT5A receptor relates such as schizophrenia,